Illustrating How to Use the Validated Alsayed_v1 Tools to Improve Medical Care: A Particular Reference to the Global Initiative for Asthma 2022 Recommendations

Purpose The current research aimed to illustrate a real case using the validated Alsayed_v1 tools as tutorial training to improve the knowledge and skills of healthcare practitioners in the clinical problem-solving process necessary to implement medical and pharmaceutical care. Patients and Methods The Alsayed_v1 instruments consist of principal components: data collection, assessment of treatments, the medical problem oriented plan (MPOP), as well as a care plan and patient education. Results This study illustrated a real case of asthma patient using the validated Alsayed_v1 tools. These validated and clinically tested tools provide a coding system for the MPOP that permits easy documentation with an open hierarchical structure where higher levels are broad and lower levels are particular, and the possibility to enter free text. The section dedicated to treatment assessments is intended to synthesize patient information to facilitate the identification of the MPOPs. Effective management requires the development of a partnership between the patient with asthma (or the patient’s caregivers) and his healthcare professional(s). This partnership aims to allow the patient to control his condition with guidance from the healthcare professional(s), discuss and agree on therapy goals, and develop a personalized, written, self-management asthma care plan. Conclusion By implementing Alsayed_v1 tools, the clinical practitioner can actively give the best practice for optimal patient outcomes.

[1]  Bushra Alshammari,et al.  Validation of an assessment, medical problem-oriented plan, and care plan tools for demonstrating the clinical pharmacist's activities , 2022, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[2]  I. Basheti,et al.  Evaluation of the effectiveness of educational medical informatics tutorial on improving pharmacy students’ knowledge and skills about the clinical problem-solving process , 2022, Pharmacy practice.

[3]  Farhan F. Alshammari,et al.  Perspectives of the community in the developing countries toward telemedicine and pharmaceutical care during the COVID-19 pandemic , 2022, Pharmacy practice.

[4]  J. Drazen,et al.  Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes. , 2021, The journal of allergy and clinical immunology. In practice.

[5]  M. Bouvy,et al.  Moral dilemmas of community pharmacists: a narrative study , 2017, International Journal of Clinical Pharmacy.

[6]  G. Murtaza,et al.  Randomized controlled trials covering pharmaceutical care and medicines management: A systematic review of literature , 2017, Research in social & administrative pharmacy : RSAP.

[7]  Hua Shao,et al.  Effect of pharmaceutical care on clinical outcomes of outpatients with type 2 diabetes mellitus , 2017, Patient preference and adherence.

[8]  R. Clark,et al.  Role of the Pharmacist for Improving Self-care and Outcomes in Heart Failure , 2017, Current Heart Failure Reports.

[9]  S. Shrestha,et al.  Benefit of hospital pharmacy intervention on the current status of dry powder inhaler technique in patients with asthma and COPD: a study from the Central Development Region, Nepal , 2016, Integrated pharmacy research & practice.

[10]  I. Basheti,et al.  Hospital pharmacy medication reconciliation practice in Jordan: perceptions and barriers. , 2016, Journal of evaluation in clinical practice.

[11]  Maurílio de Souza Cazarim,et al.  Impact Assessment of Pharmaceutical Care in the Management of Hypertension and Coronary Risk Factors after Discharge , 2016, PloS one.

[12]  J. Ho,et al.  Pharmacist review and its impact on Singapore nursing homes. , 2015, Singapore medical journal.

[13]  S. Aburuz,et al.  The case for evidence-based pharmaceutical care. , 2015, Research in social & administrative pharmacy : RSAP.

[14]  R. Tamblyn,et al.  Educating medical trainees on medication reconciliation: a systematic review , 2015, BMC medical education.

[15]  A. Hussain,et al.  The changing face of pharmacy practice and the need for a new model of pharmacy education. , 2013, Journal of young pharmacists : JYP.

[16]  A. Sabzghabaee,et al.  Pharmaceutical care for asthma patients: A Developing Country's Experience , 2012, Journal of research in pharmacy practice.

[17]  H. Wollersheim,et al.  Medication reconciliation at hospital admission and discharge: insufficient knowledge, unclear task reallocation and lack of collaboration as major barriers to medication safety , 2012, BMC Health Services Research.

[18]  M. Schulz,et al.  Development of a classification system for drug‐related problems in the hospital setting (APS‐Doc) and assessment of the inter‐rater reliability , 2012, Journal of clinical pharmacy and therapeutics.

[19]  W. Kuhn,et al.  Pharmaceutical care for patients with breast and ovarian cancer , 2012, Supportive Care in Cancer.

[20]  P. R. Obreli-Neto,et al.  Effect of a 36-month pharmaceutical care program on pharmacotherapy adherence in elderly diabetic and hypertensive patients , 2011, International Journal of Clinical Pharmacy.

[21]  C. Bradley The future role of pharmacists in primary care. , 2009, The British journal of general practice : the journal of the Royal College of General Practitioners.

[22]  S. Aburuz,et al.  Validation of a comprehensive classification tool for treatment-related problems , 2006, Pharmacy World and Science.

[23]  A. Siu,et al.  Medication reconciliation for reducing drug-discrepancy adverse events. , 2006, The American journal of geriatric pharmacotherapy.

[24]  Carole W Cranor,et al.  The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. , 2006, Journal of the American Pharmacists Association : JAPhA.

[25]  R. Clifford,et al.  Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. , 2005, Diabetes care.

[26]  E. Roughead,et al.  Pharmaceutical care services: a systematic review of published studies, 1990 to 2003, examining effectiveness in improving patient outcomes , 2005 .

[27]  M. J. Martín-Calero,et al.  Pharmaceutical care: past, present and future. , 2004, Current pharmaceutical design.

[28]  C. D. Hepler Clinical Pharmacy, Pharmaceutical Care, and the Quality of Drug Therapy , 2004, Pharmacotherapy.

[29]  D. Christensen,et al.  The asheville project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. , 2003, Journal of the American Pharmaceutical Association.

[30]  C. Raehl,et al.  Clinical Pharmacy Services, Hospital Pharmacy Staffing, and Medication Errors in United States Hospitals , 2002, Pharmacotherapy.

[31]  C. Hepler,et al.  Opportunities and responsibilities in pharmaceutical care. , 1990, American journal of hospital pharmacy.

[32]  L. Hasoun,et al.  Potentially inappropriate medications use and its associated factors among geriatric patients: a cross-sectional study based on 2019 Beers Criteria , 2021, Pharmacia.

[33]  L. Strand,et al.  Pharmaceutical care practice : the patient-centered approach to medication management services , 2012 .

[34]  Multinational Association of Supportive Care in Cancer , 2007 .